Dr. Lash is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1430 Eagle Bend Dr
Southlake, TX 76092Phone+1 817-251-2040
Education & Training
Cleveland Clinic FoundationFellowship, Gastrointestinal Pathology, 1987 - 1988- Cleveland Clinic FoundationResidency, Pathology-Anatomic and Clinical, 1983 - 1987
University of Michigan Medical SchoolClass of 1983
Certifications & Licensure
NY State Medical License 2007 - 2027
TX State Medical License 2005 - 2025
OH State Medical License 1987 - 2021
FL State Medical License 2004 - 2020
AZ State Medical License 2005 - 2019
PA State Medical License 2003 - 2018- American Board of Pathology Anatomic Pathology & Clinical Pathology
Awards, Honors, & Recognition
- Fellow (FCAP) College of American Pathologists, 1987
- AOA Alpha Omega Alpha Medical Society, 1982
- Fellow (AGAF) American Gastroenterological Association, 2012
Publications & Presentations
PubMed
- 37 citationsAbnormal TP53 Predicts Risk of Progression in Patients With Barrett's Esophagus Regardless of a Diagnosis of Dysplasia.Mark Redston, Amy Noffsinger, Anthony Kim, Fahire G Akarca, Marianne Rara
Gastroenterology. 2021-10-29 - 17 citationsGene expression-phenotype associations in adults with eosinophilic esophagitis.Evan S. Dellon, Sara R. Selitsky, Robert M. Genta, Richard H. Lash, Joel S. Parker
Digestive and Liver Disease. 2018-08-01 - 94 citationsDetection of Mutations in Barrett's Esophagus Before Progression to High-Grade Dysplasia or Adenocarcinoma.Matthew D. Stachler, Nicholas D. Camarda, Christopher Deitrick, Anthony Kim, Agoston T. Agoston
Gastroenterology. 2018-07-01
Press Mentions
Is Sixth Drug in InformTx™ Therapeutic Drug Monitoring Service from Miraca Life SciencesMarch 28th, 2017
Stelara® Now Available for Therapeutic Drug Monitoring from Miraca Life SciencesDecember 1st, 2016- EoGenius™ Test for Eosinophilic Esophagitis Launched by Miraca Life SciencesMarch 2nd, 2016
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
